Skip to main content
Clinical Trials/ACTRN12611001242910
ACTRN12611001242910
Recruiting
N/A

Evaluation by histopathology examination and immunohistochemistry on TRUS-guided prostate biopsy samples of the presence, location, extension and grade of tumor (Gleason score) in patients with suspicion of prostate cancer

MedNewLife Medical Center0 sites100 target enrollmentDecember 6, 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
MedNewLife Medical Center
Enrollment
100
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 6, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
MedNewLife Medical Center

Eligibility Criteria

Inclusion Criteria

  • clinical/biochemical suspicion of prostate cancer
  • (positive digital rectal examination \- DRE and/or
  • prostate specific antigen \- PSA \>\= 2\.5 ng/ml)

Exclusion Criteria

  • There are no exclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials